The editorial staff of Europe 1 5:00 p.m., November 17, 2021

The American pharmaceutical giant Pfizer has agreed to let its anti-Covid-19 pill circulate to 95 countries, or 53% of the world's population, in order to fight the pandemic.

If its promising results are confirmed, the availability of treatment "will be a matter of months."